Evidence map›Paper›PMID 37310207›Full record

ArticleeLife2023

Three-dimensional imaging of vascular development in the mouse epididymis.

Christelle Damon-Soubeyrand, Antonino Bongiovanni, Areski Chorfa, Chantal Goubely, Nelly Pirot, Luc Pardanaud, Laurence Piboin-Fragner, Caroline Vachias, Stephanie Bravard, Rachel Guiton and 6 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 2 countries.

Christelle Damon-Soubeyrand *Institut « Génétique Reproduction & Développement », UMR CNRS 6293 - Inserm U1103 - Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France.
Antonino Bongiovanni *Université Lille, CNRS, Inserm, CHU Lille, US 41 - UAR 2014-PLBS, Lille, France.ORCID 0000-0001-9876-2940
Areski Chorfa *Institut « Génétique Reproduction & Développement », UMR CNRS 6293 - Inserm U1103 - Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France.
Chantal GoubelyInstitut « Génétique Reproduction & Développement », UMR CNRS 6293 - Inserm U1103 - Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France.
Nelly PirotRéseau d'Histologie Expérimentale de Montpellier, Institut de Recherche en Cancérologie de Montpellier, Inserm U1194 - Université Montpellier - ICM, Campus Val d'Aurelle, Montpellier, France.
Luc PardanaudUniversité de Paris, PARCC, INSERM, Paris, France.
Laurence Piboin-FragnerUniversité de Paris, PARCC, INSERM, Paris, France.
Caroline VachiasInstitut « Génétique Reproduction & Développement », UMR CNRS 6293 - Inserm U1103 - Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France.
Stephanie BravardInstitut « Génétique Reproduction & Développement », UMR CNRS 6293 - Inserm U1103 - Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France.
Rachel GuitonInstitut « Génétique Reproduction & Développement », UMR CNRS 6293 - Inserm U1103 - Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France.
Jean-Leon ThomasDepartment of Neurology, Yale University School of Medicine, New Haven, United States.
Fabrice SaezInstitut « Génétique Reproduction & Développement », UMR CNRS 6293 - Inserm U1103 - Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France.
Ayhan KocerInstitut « Génétique Reproduction & Développement », UMR CNRS 6293 - Inserm U1103 - Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France.
Meryem TardivelUniversité Lille, CNRS, Inserm, CHU Lille, US 41 - UAR 2014-PLBS, Lille, France.
Joël R DrevetInstitut « Génétique Reproduction & Développement », UMR CNRS 6293 - Inserm U1103 - Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France.ORCID 0000-0003-3077-6558
Joelle Henry-BergerInstitut « Génétique Reproduction & Développement », UMR CNRS 6293 - Inserm U1103 - Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France.ORCID 0000-0002-5107-8663
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long considered an accessory tubule of the male reproductive system, the epididymis is proving to be a key determinant of male fertility. In addition to its secretory role in ensuring functional maturation and survival of spermatozoa, the epididymis has a complex immune function. Indeed, it must manage both peripheral tolerance to sperm antigens foreign to the immune system and the protection of spermatozoa as well as the organ itself against pathogens ascending the epididymal tubule. Although our knowledge of the immunobiology of this organ is beginning to accumulate at the molecular and cellular levels, the organization of blood and lymphatic networks of this tissue, important players in the immune response, remains largely unknown. In the present report, we have taken advantage of a VEGFR3:YFP transgenic mouse model. Using high-resolution three-dimensional (3D) imaging and organ clearing coupled with multiplex immunodetections of lymphatic (LYVE1, PDPN, PROX1) and/or blood (PLVAP/Meca32) markers, we provide a simultaneous deep 3D view of the lymphatic and blood epididymal vasculature in the mature adult mouse as well as during postnatal development.

Indexed as

EpididymisImaging, Three-DimensionalAnimalsMaleMiceMice, TransgenicSemenSpermatozoadevelopmental biologyepididymislymphaticsmousespermatozoa

Identifiers

PMID37310207
PMCPMC10264076
OpenAlexW4380422958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.